Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

HLN vs KVUE

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
HLN
Haleon plc

Drug Manufacturers - Specialty & Generic

HealthcareNYSE • GB
Market Cap$41.10B
5Y Perf.+14.8%
KVUE
Kenvue Inc.

Household & Personal Products

Consumer DefensiveNYSE • US
Market Cap$33.87B
5Y Perf.-29.5%

HLN vs KVUE — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
HLN logoHLN
KVUE logoKVUE
IndustryDrug Manufacturers - Specialty & GenericHousehold & Personal Products
Market Cap$41.10B$33.87B
Revenue (TTM)$22.01B$15.01B
Net Income (TTM)$3.18B$1.43B
Gross Margin63.9%58.1%
Operating Margin21.4%15.7%
Forward P/E22.0x15.5x
Total Debt$8.59B$8.72B
Cash & Equiv.$1.32B$1.07B

HLN vs KVUELong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

HLN
KVUE
StockMay 23May 26Return
Haleon plc (HLN)100114.8+14.8%
Kenvue Inc. (KVUE)10070.5-29.5%

Price return only. Dividends and distributions are not included.

Quick Verdict: HLN vs KVUE

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: HLN leads in 4 of 7 categories, making it the strongest pick for profitability and margin quality and capital preservation and lower volatility. Kenvue Inc. is the stronger pick specifically for growth and revenue expansion and valuation and capital efficiency. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
HLN
Haleon plc
The Income Pick

HLN carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.

  • Dividend streak 2 yrs, beta 0.06, yield 2.0%
  • 30.6% 10Y total return vs KVUE's -25.9%
  • Lower volatility, beta 0.06, Low D/E 52.2%, current ratio 0.92x
Best for: income & stability and long-term compounding
KVUE
Kenvue Inc.
The Growth Play

KVUE is the clearest fit if your priority is growth exposure and defensive.

  • Rev growth 0.1%, EPS growth -37.9%, 3Y rev CAGR 0.9%
  • Beta 0.24, yield 4.6%, current ratio 0.96x
  • 0.1% revenue growth vs HLN's -4.0%
Best for: growth exposure and defensive
See the full category breakdown
CategoryWinnerWhy
GrowthKVUE logoKVUE0.1% revenue growth vs HLN's -4.0%
ValueKVUE logoKVUELower P/E (15.5x vs 22.0x)
Quality / MarginsHLN logoHLN14.5% margin vs KVUE's 9.5%
Stability / SafetyHLN logoHLNBeta 0.06 vs KVUE's 0.24, lower leverage
DividendsKVUE logoKVUE4.6% yield, vs HLN's 2.0%
Momentum (1Y)HLN logoHLN-11.7% vs KVUE's -21.5%
Efficiency (ROA)HLN logoHLN10.0% ROA vs KVUE's 5.3%, ROIC 7.6% vs 7.8%

HLN vs KVUE — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

HLNHaleon plc
FY 2022
Respiratory Health
100.0%$1.6B
KVUEKenvue Inc.
FY 2024
Self Care
42.2%$6.5B
Essential Health
30.3%$4.7B
Skin Health and Beauty
27.4%$4.2B

HLN vs KVUE — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLHLNLAGGINGKVUE

Income & Cash Flow (Last 12 Months)

HLN leads this category, winning 6 of 6 comparable metrics.

HLN and KVUE operate at a comparable scale, with $22.0B and $15.0B in trailing revenue. Profitability is closely matched — net margins range from 14.5% (HLN) to 9.5% (KVUE). On growth, HLN holds the edge at -0.4% YoY revenue growth, suggesting stronger near-term business momentum.

MetricHLN logoHLNHaleon plcKVUE logoKVUEKenvue Inc.
RevenueTrailing 12 months$22.0B$15.0B
EBITDAEarnings before interest/tax$5.3B$2.9B
Net IncomeAfter-tax profit$3.2B$1.4B
Free Cash FlowCash after capex$3.1B$1.6B
Gross MarginGross profit ÷ Revenue+63.9%+58.1%
Operating MarginEBIT ÷ Revenue+21.4%+15.7%
Net MarginNet income ÷ Revenue+14.5%+9.5%
FCF MarginFCF ÷ Revenue+14.2%+10.9%
Rev. Growth (YoY)Latest quarter vs prior year-0.4%-3.5%
EPS Growth (YoY)Latest quarter vs prior year+18.8%+5.0%
HLN leads this category, winning 6 of 6 comparable metrics.

Valuation Metrics

HLN leads this category, winning 4 of 6 comparable metrics.

At 18.9x trailing earnings, HLN trades at a 42% valuation discount to KVUE's 32.7x P/E. On an enterprise value basis, HLN's 13.5x EV/EBITDA is more attractive than KVUE's 16.9x.

MetricHLN logoHLNHaleon plcKVUE logoKVUEKenvue Inc.
Market CapShares × price$41.1B$33.9B
Enterprise ValueMkt cap + debt − cash$51.0B$41.5B
Trailing P/EPrice ÷ TTM EPS18.87x32.74x
Forward P/EPrice ÷ next-FY EPS est.22.03x15.54x
PEG RatioP/E ÷ EPS growth rate2.23x
EV / EBITDAEnterprise value multiple13.53x16.86x
Price / SalesMarket cap ÷ Revenue2.80x2.19x
Price / BookPrice ÷ Book value/share1.86x3.52x
Price / FCFMarket cap ÷ FCF15.35x25.37x
HLN leads this category, winning 4 of 6 comparable metrics.

Profitability & Efficiency

HLN leads this category, winning 7 of 9 comparable metrics.

HLN delivers a 19.9% return on equity — every $100 of shareholder capital generates $20 in annual profit, vs $13 for KVUE. HLN carries lower financial leverage with a 0.52x debt-to-equity ratio, signaling a more conservative balance sheet compared to KVUE's 0.90x. On the Piotroski fundamental quality scale (0–9), HLN scores 8/9 vs KVUE's 5/9, reflecting strong financial health.

MetricHLN logoHLNHaleon plcKVUE logoKVUEKenvue Inc.
ROE (TTM)Return on equity+19.9%+13.5%
ROA (TTM)Return on assets+10.0%+5.3%
ROICReturn on invested capital+7.6%+7.8%
ROCEReturn on capital employed+8.6%+8.7%
Piotroski ScoreFundamental quality 0–985
Debt / EquityFinancial leverage0.52x0.90x
Net DebtTotal debt minus cash$7.3B$7.6B
Cash & Equiv.Liquid assets$1.3B$1.1B
Total DebtShort + long-term debt$8.6B$8.7B
Interest CoverageEBIT ÷ Interest expense7.80x5.22x
HLN leads this category, winning 7 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

HLN leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in HLN five years ago would be worth $13,065 today (with dividends reinvested), compared to $7,406 for KVUE. Over the past 12 months, HLN leads with a -11.7% total return vs KVUE's -21.5%. The 3-year compound annual growth rate (CAGR) favors HLN at 3.1% vs KVUE's -9.1% — a key indicator of consistent wealth creation.

MetricHLN logoHLNHaleon plcKVUE logoKVUEKenvue Inc.
YTD ReturnYear-to-date-6.4%+3.3%
1-Year ReturnPast 12 months-11.7%-21.5%
3-Year ReturnCumulative with dividends+9.6%-24.8%
5-Year ReturnCumulative with dividends+30.6%-25.9%
10-Year ReturnCumulative with dividends+30.6%-25.9%
CAGR (3Y)Annualised 3-year return+3.1%-9.1%
HLN leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

HLN leads this category, winning 2 of 2 comparable metrics.

HLN is the less volatile stock with a 0.06 beta — it tends to amplify market swings less than KVUE's 0.24 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. HLN currently trades 80.8% from its 52-week high vs KVUE's 70.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricHLN logoHLNHaleon plcKVUE logoKVUEKenvue Inc.
Beta (5Y)Sensitivity to S&P 5000.06x0.24x
52-Week HighHighest price in past year$11.42$25.17
52-Week LowLowest price in past year$8.71$14.02
% of 52W HighCurrent price vs 52-week peak+80.8%+70.2%
RSI (14)Momentum oscillator 0–10033.148.3
Avg Volume (50D)Average daily shares traded7.9M20.0M
HLN leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Evenly matched — HLN and KVUE each lead in 1 of 2 comparable metrics.

Wall Street rates HLN as "Buy" and KVUE as "Hold". Consensus price targets imply 10.5% upside for HLN (target: $10) vs 3.2% for KVUE (target: $18). For income investors, KVUE offers the higher dividend yield at 4.56% vs HLN's 1.96%.

MetricHLN logoHLNHaleon plcKVUE logoKVUEKenvue Inc.
Analyst RatingConsensus buy/hold/sellBuyHold
Price TargetConsensus 12-month target$10.20$18.25
# AnalystsCovering analysts414
Dividend YieldAnnual dividend ÷ price+2.0%+4.6%
Dividend StreakConsecutive years of raises20
Dividend / ShareAnnual DPS$0.13$0.81
Buyback YieldShare repurchases ÷ mkt cap+2.1%+0.7%
Evenly matched — HLN and KVUE each lead in 1 of 2 comparable metrics.
Key Takeaway

HLN leads in 5 of 6 categories — strongest in Income & Cash Flow and Valuation Metrics. 1 category is tied.

Best OverallHaleon plc (HLN)Leads 5 of 6 categories
Loading custom metrics...

HLN vs KVUE: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is HLN or KVUE a better buy right now?

For growth investors, Kenvue Inc.

(KVUE) is the stronger pick with 0. 1% revenue growth year-over-year, versus -4. 0% for Haleon plc (HLN). Haleon plc (HLN) offers the better valuation at 18. 9x trailing P/E (22. 0x forward), making it the more compelling value choice. Analysts rate Haleon plc (HLN) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — HLN or KVUE?

On trailing P/E, Haleon plc (HLN) is the cheapest at 18.

9x versus Kenvue Inc. at 32. 7x. On forward P/E, Kenvue Inc. is actually cheaper at 15. 5x — notably different from the trailing picture, reflecting expected earnings growth.

03

Which is the better long-term investment — HLN or KVUE?

Over the past 5 years, Haleon plc (HLN) delivered a total return of +30.

6%, compared to -25. 9% for Kenvue Inc. (KVUE). Over 10 years, the gap is even starker: HLN returned +30. 6% versus KVUE's -25. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — HLN or KVUE?

By beta (market sensitivity over 5 years), Haleon plc (HLN) is the lower-risk stock at 0.

06β versus Kenvue Inc. 's 0. 24β — meaning KVUE is approximately 297% more volatile than HLN relative to the S&P 500. On balance sheet safety, Haleon plc (HLN) carries a lower debt/equity ratio of 52% versus 90% for Kenvue Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — HLN or KVUE?

By revenue growth (latest reported year), Kenvue Inc.

(KVUE) is pulling ahead at 0. 1% versus -4. 0% for Haleon plc (HLN). On earnings-per-share growth, the picture is similar: Haleon plc grew EPS 12. 5% year-over-year, compared to -37. 9% for Kenvue Inc.. Over a 3-year CAGR, KVUE leads at 0. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — HLN or KVUE?

Haleon plc (HLN) is the more profitable company, earning 15.

1% net margin versus 6. 7% for Kenvue Inc. — meaning it keeps 15. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HLN leads at 22. 4% versus 11. 9% for KVUE. At the gross margin level — before operating expenses — HLN leads at 64. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is HLN or KVUE more undervalued right now?

On forward earnings alone, Kenvue Inc.

(KVUE) trades at 15. 5x forward P/E versus 22. 0x for Haleon plc — 6. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for HLN: 10. 5% to $10. 20.

08

Which pays a better dividend — HLN or KVUE?

All stocks in this comparison pay dividends.

Kenvue Inc. (KVUE) offers the highest yield at 4. 6%, versus 2. 0% for Haleon plc (HLN).

09

Is HLN or KVUE better for a retirement portfolio?

For long-horizon retirement investors, Haleon plc (HLN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

06), 2. 0% yield). Both have compounded well over 10 years (HLN: +30. 6%, KVUE: -25. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between HLN and KVUE?

These companies operate in different sectors (HLN (Healthcare) and KVUE (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: HLN is a mid-cap quality compounder stock; KVUE is a mid-cap income-oriented stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

HLN

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Net Margin > 8%
  • Dividend Yield > 0.7%
Run This Screen
Stocks Like

KVUE

Income & Dividend Stock

  • Sector: Consumer Defensive
  • Market Cap > $100B
  • Net Margin > 5%
  • Dividend Yield > 1.8%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform HLN and KVUE on the metrics below

Revenue Growth>
%
(HLN: -0.4% · KVUE: -3.5%)
Net Margin>
%
(HLN: 14.5% · KVUE: 9.5%)
P/E Ratio<
x
(HLN: 18.9x · KVUE: 32.7x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.